NCT02756221

Brief Summary

The study will evaluate the change in gastrointestinal (GI) flora following probiotic supplementation, and expected to lead to an increase in the intestinal epithelial integrity and to improvement in its health. Concurrently with the reduction in the amount of toxins in the GI tract following an intensive exercise, a lower incidence of symptoms of discomfort will improve the quality of the training sessions which will be exhibited by an improvement in endurance capacity and in physiological responses to rigorous exercise. Half of the participants will receive probiotic supplement while the other half will receive a placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 11, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 29, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2018

Completed
Last Updated

April 25, 2018

Status Verified

April 1, 2018

Enrollment Period

2.1 years

First QC Date

April 11, 2016

Last Update Submit

April 23, 2018

Conditions

Keywords

symptoms

Outcome Measures

Primary Outcomes (4)

  • Maximal oxygen consumption (VO2max)

    Maximal oxygen consumption (VO2max, l/min, or ml/min/kg) is expected to rise following 2 months of supplementation

    90 days

  • Ventilatory threshold (VTH)

    Ventilatory threshold (VTH), determined during a graded exercise test which measures maximal oxygen consumption (VO2max), and is the deflection point of CO2 production vs VO2 and is expressed as the running speed (km/h) at which it is occurs, and also as percentage of VO2max. Following 3 months of supplementation a right shift in the VTH curve is expected indicating an improved aerobic endurance, meaning that it is occurring at a higher running velocity (km/h)

    90 days

  • Running economy

    Running economy calculated from the slope of oxygen consumption (VO2) vs 3-4 submaximal running velocities (km/h) is expected to improve, the lower the slope (Liter Oxygen/km/hour) the better the running economy

    90 days

  • Time to Fatigue

    Time to fatigue (minute; seconds) calculated as at exercise intensity of 85-88% of VO2max is expected to rise, increased time to fatigue indicates improved aerobic endurance

    90 days

Study Arms (2)

Probiotics

EXPERIMENTAL

Probiotics capsules, one capsule daily for 90 days.

Dietary Supplement: Probiotics

Placebo

PLACEBO COMPARATOR

Starch capsules, one capsule daily for 90 days

Other: Placebo

Interventions

ProbioticsDIETARY_SUPPLEMENT

One capsule per day for 90 days. Containing 8 x 109 CFU of bacteria /capsule Lactobacillus heleveticus Lafti L10 Bifidobacterium animalis ssp lactis Lafti B94 Enterococcus faecium Rosell-26 Bifidobacterium longum RO175 Bacillus subtills Rosell-179 Inactive ingredients: potato starch, magnesium stearate, ascorbic acid White vegetable capsule size 1

Also known as: Taam Teva Digestion Caps
Probiotics
PlaceboOTHER

Placebo capsules identical in shape and color to the probiotics capsules, one capsule per day for 90 days

Placebo

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age 18-60 years
  • at least 3 years of national-level experience, including participation in competitions
  • suffer from one or more of the following symptoms: nausea, vomiting, belching, heartburn and chest pain, bloating, cramps, side pain, urge to empty bowels and diarrhea during training and competitions

You may not qualify if:

  • Diagnosis of gastrointestinal diseases
  • Diagnosis of heart diseases
  • Use of Probiotics during the 3 months' period prior to the study
  • Use of Antibiotics during the 3 months' period prior to the study
  • A radical surgery in the digestive system during the year prior to the

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Physiology Laboratory

Tel H̱ay, Israel

Location

Related Publications (3)

  • Clarke SF, Murphy EF, O'Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O'Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O'Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014 Dec;63(12):1913-20. doi: 10.1136/gutjnl-2013-306541. Epub 2014 Jun 9.

  • Coyle EF. Integration of the physiological factors determining endurance performance ability. Exerc Sport Sci Rev. 1995;23:25-63.

  • Schreiber C, Tamir S, Golan R, Weinstein A, Weinstein Y. The effect of probiotic supplementation on performance, inflammatory markers and gastro-intestinal symptoms in elite road cyclists. J Int Soc Sports Nutr. 2021 May 17;18(1):36. doi: 10.1186/s12970-021-00432-6.

MeSH Terms

Conditions

Gastroenteritis

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Ron Golan, MD

    Ziv Medical Center, Zefat, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head Exercise Physiology Laboratory

Study Record Dates

First Submitted

April 11, 2016

First Posted

April 29, 2016

Study Start

March 1, 2016

Primary Completion

April 23, 2018

Study Completion

April 23, 2018

Last Updated

April 25, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will share

Anonymous individual subjects data for all outcome measures will be made available within 12 months of study completion

Locations